Latest Functional colonic disease Stories

May Issue of The American Journal of Gastroenterology Features IBS, Celiac Disease, Fatty Liver BETHESDA, Md., May 7, 2013 /PRNewswire-USNewswire/ -- The May 2013 issue of The American Journal of Gastroenterology presents new research and systematic reviews on the theme of food in gastrointestinal disorders that includes two new clinical guidelines from the American College of Gastroenterology, Diagnosis and Management of Celiac Disease by Dr. Joseph Murray and Dr. Alberto...

Investigators honored for study of functional GI and motility disorders MILWAUKEE, April 12, 2013 /PRNewswire/ -- The International Foundation for Functional Gastrointestinal Disorders (IFFGD), recognizing the importance of scientific advancement in the area of chronic digestive disorders, awards eight investigators with its 2013 Research Awards. The honorees will be recognized at the 10(th) International Symposium on Functional Gastrointestinal Disorders. Since 2003 IFFGD, a...

IFFGD Looks at Irritable Bowel Syndrome (IBS) and Progress to Improve Treatment for Returning Military MILWAUKEE, April 1, 2013 /PRNewswire/ -- Many veterans returning from service in Gulf War regions are finding themselves faced with gastrointestinal problems. During April, IBS Awareness Month, the International Foundation for Functional Gastrointestinal Disorders (IFFGD) highlights recent developments to improve treatment of chronic digestive issues for these servicemen and women....

BARCELONA, Spain and CAMBRIDGE, Massachusetts, November 28, 2012 /PRNewswire/ -- - Constella(R) (linaclotide) is the first and only medicine approved by the European Commission for the symptomatic treatment of moderate to severe IBS-C in adults, that improves abdominal pain/discomfort, bloating and constipation - First launches in Europe are expected in the first half of 2013 - IBS-C is a functional gastrointestinal disorder...

Patients with irritable bowel syndrome (IBS) have a significantly greater prevalence of early adverse life events , including general trauma as well as physical, emotional and sexual abuse, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association. "Various types of early adverse events are associated with the development of irritable bowel syndrome, particularly among women," said Lin Chang, MD, of the David...

MILWAUKEE, March 21, 2012 /PRNewswire/ -- High numbers of veterans returning from the Gulf War regions of Iraq and Afghanistan are experiencing symptoms of irritable bowel syndrome (IBS) and other functional gastrointestinal (GI) disorders. This prompted the Department of Veterans Affairs (VA) last August to implement a new rule for the purposes of assessing disability benefits. Veterans deployed during the Gulf War who now suffer with a functional GI disorder are presumed to have...

BARCELONA, Spain, September 29, 2011 /PRNewswire/ -- - Linaclotide has demonstrated statistically significant improvement in abdominal pain/discomfort and global relief of IBS-C symptoms in Phase III clinical trials [1,2] - IBS-C is a debilitating disease associated with reduced quality of life and considerable socio-economic and psychological consequences [3,4] Almirall, S.A. (ALM.MC) announced today that it has submitted a Marketing Authorisation Application...

MILWAUKEE, June 23, 2011 /PRNewswire/ -- A bill to expand federal research of functional gastrointestinal (GI) and motility disorders, such as IBS, GERD and gastroparesis, has been introduced in the U.S. House of Representatives. The Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2011 (H.R. 2239) was introduced by original cosponsors Rep. James Sensenbrenner (R-WI-5) and Rep. Jim Moran (D-VA-8) on June 16. The proposed legislation was drafted by the...

MILWAUKEE, March 29, 2011 /PRNewswire/ -- IBS (Irritable Bowel Syndrome) symptoms often go away and reappear again. While this usually does not signify the development of a new digestive disorder, during April, IBS Awareness Month, the International Foundation for Functional Gastrointestinal Disorders (IFFGD) wants to remind patients of red flags and personal risk factors that indicate a need to revisit the doctor. IBS affects about 10 to 15 percent of the population. The key symptoms are...

Functional GI Disorders Are Common, Comprise about 40 percent of GI Diagnoses BETHESDA, Md., April 6 /PRNewswire-USNewswire/ -- New clinical algorithms will give physicians a practical, efficient and cost-effective aid to diagnose the frequent gastrointestinal symptoms that patients commonly bring to their primary care doctors and gastroenterologists--symptoms of functional GI disorders that are often difficult to diagnose. Developed by the Rome Foundation and published in the April issue...